{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:15:00Z","timestamp":1790766900813,"version":"4.1.0"},"reference-count":120,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1072127"],"award-info":[{"award-number":["APP1072127"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Despite global vaccination efforts, influenza virus continues to cause yearly epidemics and periodic pandemics throughout most of the world. Many of us consider the generation of broader, potent and long-lasting immunity against influenza viruses as critical in curtailing the global health and economic impact that influenza currently plays. To date, classical vaccinology has relied on the generation of neutralizing antibodies as the benchmark to measure vaccine effectiveness. However, recent developments in numerous related fields of biomedical research including, HIV, HSV and DENV have emphasized the importance of Fc-mediate effector functions in pathogenesis and immunity. The concept of Fc effector functions in contributing to protection from illness is not a new concept and has been investigated in the field for over four decades. However, in recent years the application and study of Fc effector functions has become revitalized with new knowledge and technologies to characterize their potential importance in immunity. In this perspective, we describe the current state of the field of Influenza Fc effector functions and discuss its potential utility in universal vaccine design in the future.<\/jats:p>","DOI":"10.3390\/vaccines6020027","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T11:47:45Z","timestamp":1526557665000},"page":"27","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The Potential Role of Fc-Receptor Functions in the Development of a Universal Influenza Vaccine"],"prefix":"10.3390","volume":"6","author":[{"given":"Sinthujan","family":"Jegaskanda","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC 3010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"ref_1","unstructured":"Organisation, W.H. (2018, January 02). Influenza (Seasonal) Fact Sheet. Available online: http:\/\/www.who.int\/mediacentre\/factsheets\/fs211\/en\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1016\/j.vaccine.2015.08.082","article-title":"Seasonal influenza vaccine dose distribution in 195 countries (2004\u20132013): Little progress in estimated global vaccination coverage","volume":"33","author":"Palache","year":"2015","journal-title":"Vaccine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.vaccine.2017.07.053","article-title":"Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004\u20132015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness","volume":"35","author":"Palache","year":"2017","journal-title":"Vaccine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1172\/JCI81104","article-title":"Focused antibody response to influenza linked to antigenic drift","volume":"125","author":"Huang","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1128\/JVI.03248-15","article-title":"Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans","volume":"90","author":"Dinis","year":"2016","journal-title":"J. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/imm.12594","article-title":"Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection","volume":"148","author":"DeDiego","year":"2016","journal-title":"Immunology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1038\/s41598-017-14931-7","article-title":"Natural and directed antigenic drift of the H1 influenza virus hemagglutinin stalk domain","volume":"7","author":"Anderson","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1016\/j.vaccine.2007.07.027","article-title":"Influenza vaccine: The challenge of antigenic drift","volume":"25","author":"Carrat","year":"2007","journal-title":"Vaccine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/jvi.48.1.52-60.1983","article-title":"Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: Multiple evolutionary pathways and sequential amino acid changes at key antigenic sites","volume":"48","author":"Both","year":"1983","journal-title":"J. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1084\/jem.148.2.383","article-title":"Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A\/PR\/8\/34 (HON1) influenza virus with monoclonal antibodies","volume":"148","author":"Gerhard","year":"1978","journal-title":"J. Exp. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1749-6632.1980.tb27964.x","article-title":"The mechanism of antigenic drift in influenza viruses: Analysis of Hong Kong (H3N2) variants with monoclonal antibodies to the hemagglutinin molecule","volume":"354","author":"Webster","year":"1980","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: A quantitative review","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0264-410X(03)00070-7","article-title":"The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines","volume":"21","author":"Nichol","year":"2003","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.vaccine.2016.11.013","article-title":"Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis","volume":"35","author":"Young","year":"2017","journal-title":"Vaccine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/infdis\/jiv313","article-title":"Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination","volume":"212","author":"Petrie","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/290713a0","article-title":"Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies","volume":"290","author":"Gerhard","year":"1981","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0092-8674(82)90135-0","article-title":"The antigenic structure of the influenza virus A\/PR\/8\/34 hemagglutinin (H1 subtype)","volume":"31","author":"Caton","year":"1982","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution","volume":"289","author":"Wilson","year":"1981","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1017\/S0022172400022610","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"Epidemiol. Infect."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/infdis\/jir661","article-title":"Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection","volume":"204","author":"Ohmit","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.bmb.a071545","article-title":"Determinants of immunity to influenza infection in man","volume":"35","author":"Potter","year":"1979","journal-title":"Br. Med. Bull."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Benoit, A., Beran, J., Devaster, J.M., Esen, M., Launay, O., Leroux-Roels, G., McElhaney, J.E., Oostvogels, L., van Essen, G.A., and Gaglani, M. (2015). Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A\/H3N2 Influenza Disease. Open Forum Infect Diseases, Oxford University Press.","DOI":"10.1093\/ofid\/ofv067"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/oxfordjournals.aje.a113408","article-title":"Influenzavirus infections in Seattle families, 1975\u20131979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness","volume":"116","author":"Fox","year":"1982","journal-title":"Am. J. Epidemiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Coudeville, L., Bailleux, F., Riche, B., Megas, F., Andre, P., and Ecochard, R. (2010). Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: Development and application of a bayesian random-effects model. BMC Med. Res. Methodol., 10.","DOI":"10.1186\/1471-2288-10-18"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Anderson, C.S., McCall, P.R., Stern, H.A., Yang, H., and Topham, D.J. (2018). Antigenic cartography of H1N1 influenza viruses using sequence-based antigenic distance calculation. BMC Bioinform., 19.","DOI":"10.1186\/s12859-018-2042-4"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.coviro.2016.12.004","article-title":"Immune history and influenza virus susceptibility","volume":"22","author":"Cobey","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Rattan, A., Pawar, S.D., Nawadkar, R., Kulkarni, N., Lal, G., Mullick, J., and Sahu, A. (2017). Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006248"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, K.B., Morrison, T.E., Dundore, D.Y., Heise, M.T., and Schultz-Cherry, S. (2011). A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017377"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nm0402-373","article-title":"Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection","volume":"8","author":"Kopf","year":"2002","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/iai.30.2.362-369.1980","article-title":"Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine","volume":"30","author":"Quinnan","year":"1980","journal-title":"Infect. Immun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4161\/hv.21025","article-title":"Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals","volume":"8","author":"Co","year":"2012","journal-title":"Hum. Vaccine Immunother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1084\/jem.147.1.265","article-title":"Hemagglutinin-specific complement-dependent cytolytic antibody response to influenza infection","volume":"147","author":"Verbonitz","year":"1978","journal-title":"J. Exp. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/vim.2014.0061","article-title":"Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in children","volume":"27","author":"Co","year":"2014","journal-title":"Viral. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/infdis\/jiv181","article-title":"High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children","volume":"212","author":"Terajima","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1128\/JVI.05193-11","article-title":"Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies","volume":"85","author":"Terajima","year":"2011","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1016\/j.vaccine.2017.09.062","article-title":"Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults","volume":"35","author":"Johnston","year":"2017","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Vanderven, H.A., Liu, L., Ana-Sosa-Batiz, F., Nguyen, T.H., Wan, Y., Wines, B., Hogarth, P.M., Tilmanis, D., Reynaldi, A., and Parsons, M.S. (2017). Fc functional antibodies in humans with severe H7N9 and seasonal influenza. JCI Insight, 6.","DOI":"10.1172\/jci.insight.92750"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ana-Sosa-Batiz, F., Vanderven, H., Jegaskanda, S., Johnston, A., Rockman, S., Laurie, K., Barr, I., Reading, P., Lichtfuss, M., and Kent, S.J. (2016). Influenza-Specific Antibody-Dependent Phagocytosis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154461"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00018-016-2366-z","article-title":"Regulation of antibody effector functions through IgG Fc N-glycosylation","volume":"74","author":"Quast","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s10875-010-9405-6","article-title":"A novel role for the IgG Fc glycan: The anti-inflammatory activity of sialylated IgG Fcs","volume":"30","author":"Anthony","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/332563a0","article-title":"Localization of the binding site for the human high-affinity Fc receptor on IgG","volume":"332","author":"Duncan","year":"1988","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1073\/pnas.80.21.6632","article-title":"Biological significance of carbohydrate chains on monoclonal antibodies","volume":"80","author":"Nose","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/6179","article-title":"Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity","volume":"17","author":"Umana","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1073\/pnas.1108455108","article-title":"Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose","volume":"108","author":"Ferrara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"Anthony","year":"2008","journal-title":"Science"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMcibr0803649","article-title":"The antiinflammatory IgG","volume":"359","author":"Kaveri","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1073\/pnas.1702173114","article-title":"Modulating IgG effector function by Fc glycan engineering","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41467-017-00928-3","article-title":"Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice","volume":"8","author":"He","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e01624-16","DOI":"10.1128\/mBio.01624-16","article-title":"Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner","volume":"7","author":"Mullarkey","year":"2016","journal-title":"MBio"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1073\/pnas.1609316113","article-title":"Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus","volume":"113","author":"He","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Simhadri, V.R., Dimitrova, M., Mariano, J.L., Zenarruzabeitia, O., Zhong, W., Ozawa, T., Muraguchi, A., Kishi, H., Eichelberger, M.C., and Borrego, F. (2015). A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124677"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2008.06.002","article-title":"Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein","volume":"80","author":"Wang","year":"2008","journal-title":"Antivir. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e02500-16","DOI":"10.1128\/JVI.02500-16","article-title":"Hierarchical and Redundant Roles of Activating FcgammaRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies","volume":"91","author":"Ehrhardt","year":"2017","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1099\/jgv.0.000518","article-title":"Cross-protective potential of anti-nucleoprotein human monoclonal antibodies against lethal influenza A virus infection","volume":"97","author":"Fujimoto","year":"2016","journal-title":"J. Gen. Virol."},{"key":"ref_61","first-page":"135","article-title":"Several protein regions contribute to determine the nuclear and cytoplasmic localization of the influenza A virus nucleoprotein","volume":"81","author":"Bullido","year":"2000","journal-title":"J. Gen. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.126.5.1814","article-title":"Expression of influenza A virus internal antigens on the surface of infected P815 cells","volume":"126","author":"Yewdell","year":"1981","journal-title":"J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/CVI.00339-13","article-title":"In vitro assessment of the immunological significance of a human monoclonal antibody directed to the influenza a virus nucleoprotein","volume":"20","author":"Bodewes","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"13418","DOI":"10.1128\/JVI.01219-14","article-title":"Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques","volume":"88","author":"Florek","year":"2014","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"Descamps","year":"2011","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: Weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1016\/j.vaccine.2014.08.030","article-title":"Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Lee, Y.N., Kim, M.C., Lee, Y.T., Hwang, H.S., Lee, J., Kim, C., and Kang, S.M. (2015). Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0137822"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/imm.12310","article-title":"Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination","volume":"143","author":"Lee","year":"2014","journal-title":"Immunology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/infdis\/jiv526","article-title":"Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)","volume":"213","author":"Sobhanie","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Zhong, W., Liu, F., Wilson, J.R., Holiday, C., Li, Z.N., Bai, Y., Tzeng, W.P., Stevens, J., York, I.A., and Levine, M.Z. (2016). Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans. Open Forum Infect Diseases, Oxford University Press.","DOI":"10.1093\/ofid\/ofw102"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e01463-17","DOI":"10.1128\/mBio.01463-17","article-title":"Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model","volume":"8","author":"Jacobsen","year":"2017","journal-title":"MBio"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/infdis\/jiw262","article-title":"Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge","volume":"214","author":"Jegaskanda","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e02284-17","DOI":"10.1128\/mBio.02284-17","article-title":"Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A\/H1N1pdm Virus","volume":"9","author":"Park","year":"2018","journal-title":"MBio"},{"key":"ref_77","first-page":"181","article-title":"Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs","volume":"14","author":"Brunner","year":"1968","journal-title":"Immunology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/infdis\/148.5.785","article-title":"Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells","volume":"148","author":"Hashimoto","year":"1983","journal-title":"J. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0022-1759(83)90438-6","article-title":"An enzyme-release assay for natural cytotoxicity","volume":"64","author":"Korzeniewski","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-1759(88)90310-9","article-title":"A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity","volume":"115","author":"Decker","year":"1988","journal-title":"J. Immunol. Methods"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/infdis\/jix554","article-title":"Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults","volume":"217","author":"Vanderven","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1128\/JVI.00273-13","article-title":"Identification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus","volume":"87","author":"Srivastava","year":"2013","journal-title":"J. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fimmu.2017.00317","article-title":"Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Head Region of Pandemic H1N1 Influenza Virus Play Detrimental Roles in H1N1-Infected Mice","volume":"8","author":"Ye","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2007.05.013","article-title":"A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: Comparisons to a 4 h 51Cr-release assay","volume":"325","author":"Kim","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1006\/meth.1996.0042","article-title":"The Cytokine Profile of Resting and Activated NK Cells","volume":"9","author":"Perussia","year":"1996","journal-title":"Methods"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.4049\/jimmunol.1701614","article-title":"IL-15 Promotes Polyfunctional NK Cell Responses to Influenza by Boosting IL-12 Production","volume":"200","author":"Wagstaffe","year":"2018","journal-title":"J. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1182\/blood-2012-08-453738","article-title":"LAMP1\/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity","volume":"121","author":"Krzewski","year":"2013","journal-title":"Blood"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2012-07-441832","article-title":"Surface CD107a\/LAMP-1 protects natural killer cells from degranulation-associated damage","volume":"122","author":"Cohnen","year":"2013","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1128\/JVI.01952-07","article-title":"Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects","volume":"82","author":"Stratov","year":"2008","journal-title":"J. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.4049\/jimmunol.182.2.1202","article-title":"Rapid degranulation of NK cells following activation by HIV-specific antibodies","volume":"182","author":"Chung","year":"2009","journal-title":"J. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1073\/pnas.1016048108","article-title":"Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure","volume":"108","author":"Chung","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies","volume":"190","author":"Jegaskanda","year":"2013","journal-title":"J. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1128\/JVI.03030-12","article-title":"Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques","volume":"87","author":"Jegaskanda","year":"2013","journal-title":"J. Virol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/infdis\/jiw346","article-title":"Preexisting Antibody-Dependent Cellular Cytotoxicity-Activating Antibody Responses Are Stable Longitudinally and Cross-reactive Responses Are Not Boosted by Recent Influenza Exposure","volume":"214","author":"Valkenburg","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.vaccine.2016.11.082","article-title":"Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection","volume":"35","author":"Nieuwkoop","year":"2017","journal-title":"Vaccine"},{"key":"ref_97","first-page":"3","article-title":"Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity","volume":"217","author":"Nieuwkoop","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"13706","DOI":"10.1128\/JVI.01666-13","article-title":"Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques","volume":"87","author":"Jegaskanda","year":"2013","journal-title":"J. Virol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/infdis\/jiu486","article-title":"Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy","volume":"211","author":"Madhavi","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e00411-17","DOI":"10.1128\/JVI.00411-17","article-title":"Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1","volume":"91","author":"Wang","year":"2017","journal-title":"J. Virol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection","volume":"19","author":"Leon","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e01603-17","DOI":"10.1128\/JVI.01603-17","article-title":"In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice","volume":"91","author":"Sutton","year":"2017","journal-title":"J. Virol."},{"key":"ref_103","first-page":"202","article-title":"Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV-New Technologies and their Impact on the HIV Vaccine Field","volume":"15","author":"Wines","year":"2017","journal-title":"Curr. HIV Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1128\/JVI.00285-16","article-title":"Antibody Responses with Fc-Mediated Functions after Vaccination of HIV-Infected Subjects with Trivalent Influenza Vaccine","volume":"90","author":"Kristensen","year":"2016","journal-title":"J. Virol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4049\/jimmunol.1502551","article-title":"Dimeric FcgammaR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG","volume":"197","author":"Wines","year":"2016","journal-title":"J. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/iai.20.3.640-645.1978","article-title":"Lymphocyte cytotoxicity to influenza virus-infected cells: Response to vaccination and virus infection","volume":"20","author":"Greenberg","year":"1978","journal-title":"Infect. Immun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.4049\/jimmunol.119.6.2100","article-title":"Lymphocyte cytotoxicity to influenza virus-infected cells. II. Requirement for antibody and non-T lymphocytes","volume":"119","author":"Greenberg","year":"1977","journal-title":"J. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/infdis\/jit294","article-title":"Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1","volume":"208","author":"Jegaskanda","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/infdis\/jiu334","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses","volume":"210","author":"Jegaskanda","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/iai.42.1.214-218.1983","article-title":"Ability of human cord blood lymphocytes to mediate antibody-dependent cellular cytotoxicity against influenza virus-infected cells","volume":"42","author":"Hashimoto","year":"1983","journal-title":"Infect. Immun."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"37341","DOI":"10.1038\/srep37341","article-title":"Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"200ra114","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"E5944","DOI":"10.1073\/pnas.1613225113","article-title":"Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact","volume":"113","author":"Leon","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fimmu.2016.00399","article-title":"Antibody-Mediated FcgammaRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids","volume":"7","author":"Cox","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/nm.4224","article-title":"Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination","volume":"22","author":"Lee","year":"2016","journal-title":"Nat. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza A viruses mediated by a single antibody loop","volume":"489","author":"Ekiert","year":"2012","journal-title":"Nature"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Zarnitsyna, V.I., Lavine, J., Ellebedy, A., Ahmed, R., and Antia, R. (2016). Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005692"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1586\/14760584.2015.1068125","article-title":"Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity","volume":"14","author":"Wheatley","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fimmu.2016.00384","article-title":"Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function","volume":"7","author":"Goodier","year":"2016","journal-title":"Front. Immunol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/6\/2\/27\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:04:40Z","timestamp":1760195080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/6\/2\/27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":120,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["vaccines6020027"],"URL":"https:\/\/doi.org\/10.3390\/vaccines6020027","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,17]]}}}